<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://insider.thefdagroup.com/p/7-audit-program-planning-moves</loc><news:news><news:publication><news:name>The FDA Group's Insider Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-27T19:03:16+00:00</news:publication_date><news:title>7 Audit Program Planning Moves to Make in Q3</news:title></news:news></url><url><loc>https://insider.thefdagroup.com/p/what-shaped-you-isnt-on-your-resume</loc><news:news><news:publication><news:name>The FDA Group's Insider Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-27T13:05:36+00:00</news:publication_date><news:title>What Shaped You Isn't on Your Resume, with Jessica Smith, PhD</news:title></news:news></url><url><loc>https://insider.thefdagroup.com/p/qmsr-fda-warning-letters</loc><news:news><news:publication><news:name>The FDA Group's Insider Newsletter</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-26T13:49:02+00:00</news:publication_date><news:title>FDA Warning Letter Breakdown: The Early QMSR Letters Keep Landing on Risk Management</news:title></news:news></url></urlset>